Sentences with phrase «lymphoma patients according»

Not exact matches

Sequencing tiny bits of DNA circulating in the blood of patients with lymphoma can accurately identify the cancer subtype and pinpoint mutations that might cause drug resistance, according to researchers at the Stanford University School of Medicine.

Patients with a history of breast cancer or lymphoma were more than three times as likely to develop heart failure — a condition in which the heart can't pump enough blood to meet the body's needs — compared with a similar group of patients who did not have cancer, according to data being presented at the American College of Cardiology's 67th Annual Scientific Patients with a history of breast cancer or lymphoma were more than three times as likely to develop heart failure — a condition in which the heart can't pump enough blood to meet the body's needs — compared with a similar group of patients who did not have cancer, according to data being presented at the American College of Cardiology's 67th Annual Scientific patients who did not have cancer, according to data being presented at the American College of Cardiology's 67th Annual Scientific Session.

According to The National Cancer Institute, 8,260 people in the United States were diagnosed with Hodgkin lymphoma last year and approximately 1,070 patients with non-Hodgkin lymphoma died from the disease in 2017.

The combination of rituximab (Rituxan) and the novel immunotherapy pidilizumab (CT - 011) is both active and well tolerated in follicular lymphoma patients, according to results of a phase II trial presented by Jason R. Westin, MD, of the MD Anderson Cancer Center in Houston, at the American Society of Hematology (ASH) meeting in Atlanta.

Anti-PD-1 antibody therapy enhances eradication of refractory Hodgkin lymphoma (HL), and when used in combination with other agents may help improve outcomes for leukemia patients, according to a report in the journal Leukemia Research.

Administration of chemotherapy to patients hospitalized with diffuse large B cell lymphoma (DLBCL) was associated with lower odds of death during hospitalization, according to the results of a study published in Cancer Epidemiology.

Progression - free survival and overall survival curves of patients with peripheral T - cell lymphoma not otherwise specified according to histone modifier gene mutations.

A combination of complementary immunotherapy drugs brentuximab vedotin (Adcetris ®) and nivolumab (Opdivo ®) destroyed most cancer cells in 64 percent of patients with recurrent Hodgkin lymphoma, according to the results of an early - phase clinical trial led by Catherine M. Diefenbach, MD, assistant professor of medicine and director of the Clinical Lymphoma lymphoma, according to the results of an early - phase clinical trial led by Catherine M. Diefenbach, MD, assistant professor of medicine and director of the Clinical Lymphoma Lymphoma Program.

Thirty - six percent of over 100 very ill lymphoma patients appeared disease - free six months after a single treatment, according to results released by the treatment's maker, Kite Pharma of Santa Monica, Calif..